NEUROCOGNITIVE FUNCTIONING IN EORTC BRAIN TUMOR GROUP RANDOMIZED PHASE II TAVAREC TRIAL (EORTC 26091, NCT01164189) ON TEMOZOLOMIDE WITH OR WITHOUT BEVACIZUMAB in 1p/19q INTACT RECURRENT GRADE II AND III GLIOMAS

Martin Klein; Jaap C. Reijneveld; Ahmed Idbaih; Walter Taal; Paul M. Clement; Filip de Vos; Antje Wick; Paul Mulholland; Martin J. B. Taphoorn; Joanne Lewis; Michael Weller; Tina Verschuere; Vassilis Golfinopoulos; Thierry Gorlia; Martin van den Bent

NEUROCOGNITIVE FUNCTIONING IN EORTC BRAIN TUMOR GROUP RANDOMIZED PHASE II TAVAREC TRIAL (EORTC 26091, NCT01164189) ON TEMOZOLOMIDE WITH OR WITHOUT BEVACIZUMAB in 1p/19q INTACT RECURRENT GRADE II AND III GLIOMAS

Martin Klein, Jaap C. Reijneveld, Ahmed Idbaih, Walter Taal, Paul M. Clement, Filip de Vos, Antje Wick, Paul Mulholland, Martin J. B. Taphoorn, Joanne Lewis, Michael Weller, Tina Verschuere, Vassilis Golfinopoulos, Thierry Gorlia, Martin van den Bent

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	139-139
Journal	Neuro-oncology
Volume	19
Publication status	Published - Nov 2017

Cite this

Klein, M., Reijneveld, J. C., Idbaih, A., Taal, W., Clement, P. M., de Vos, F., Wick, A., Mulholland, P., Taphoorn, M. J. B., Lewis, J., Weller, M., Verschuere, T., Golfinopoulos, V., Gorlia, T., & van den Bent, M. (2017). NEUROCOGNITIVE FUNCTIONING IN EORTC BRAIN TUMOR GROUP RANDOMIZED PHASE II TAVAREC TRIAL (EORTC 26091, NCT01164189) ON TEMOZOLOMIDE WITH OR WITHOUT BEVACIZUMAB in 1p/19q INTACT RECURRENT GRADE II AND III GLIOMAS. Neuro-oncology, 19, 139-139.

@article{620e67e38d4d4224a7336a7fc27cfc6d,

title = "NEUROCOGNITIVE FUNCTIONING IN EORTC BRAIN TUMOR GROUP RANDOMIZED PHASE II TAVAREC TRIAL (EORTC 26091, NCT01164189) ON TEMOZOLOMIDE WITH OR WITHOUT BEVACIZUMAB in 1p/19q INTACT RECURRENT GRADE II AND III GLIOMAS",

author = "Martin Klein and Reijneveld, {Jaap C.} and Ahmed Idbaih and Walter Taal and Clement, {Paul M.} and {de Vos}, Filip and Antje Wick and Paul Mulholland and Taphoorn, {Martin J. B.} and Joanne Lewis and Michael Weller and Tina Verschuere and Vassilis Golfinopoulos and Thierry Gorlia and {van den Bent}, Martin",

year = "2017",

month = nov,

language = "English",

volume = "19",

pages = "139--139",

journal = "Neuro-oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

}

Klein, M , Reijneveld, JC, Idbaih, A, Taal, W, Clement, PM, de Vos, F, Wick, A, Mulholland, P, Taphoorn, MJB, Lewis, J, Weller, M, Verschuere, T, Golfinopoulos, V, Gorlia, T & van den Bent, M 2017, 'NEUROCOGNITIVE FUNCTIONING IN EORTC BRAIN TUMOR GROUP RANDOMIZED PHASE II TAVAREC TRIAL (EORTC 26091, NCT01164189) ON TEMOZOLOMIDE WITH OR WITHOUT BEVACIZUMAB in 1p/19q INTACT RECURRENT GRADE II AND III GLIOMAS', Neuro-oncology, vol. 19, pp. 139-139.

NEUROCOGNITIVE FUNCTIONING IN EORTC BRAIN TUMOR GROUP RANDOMIZED PHASE II TAVAREC TRIAL (EORTC 26091, NCT01164189) ON TEMOZOLOMIDE WITH OR WITHOUT BEVACIZUMAB in 1p/19q INTACT RECURRENT GRADE II AND III GLIOMAS. / Klein, Martin ; Reijneveld, Jaap C.; Idbaih, Ahmed et al.
In: Neuro-oncology, Vol. 19, 11.2017, p. 139-139.

Research output: Contribution to journal › Meeting Abstract › Academic

TY - JOUR

T1 - NEUROCOGNITIVE FUNCTIONING IN EORTC BRAIN TUMOR GROUP RANDOMIZED PHASE II TAVAREC TRIAL (EORTC 26091, NCT01164189) ON TEMOZOLOMIDE WITH OR WITHOUT BEVACIZUMAB in 1p/19q INTACT RECURRENT GRADE II AND III GLIOMAS

AU - Klein, Martin

AU - Reijneveld, Jaap C.

AU - Idbaih, Ahmed

AU - Taal, Walter

AU - Clement, Paul M.

AU - de Vos, Filip

AU - Wick, Antje

AU - Mulholland, Paul

AU - Taphoorn, Martin J. B.

AU - Lewis, Joanne

AU - Weller, Michael

AU - Verschuere, Tina

AU - Golfinopoulos, Vassilis

AU - Gorlia, Thierry

AU - van den Bent, Martin

PY - 2017/11

Y1 - 2017/11

M3 - Meeting Abstract

SN - 1522-8517

VL - 19

SP - 139

EP - 139

JO - Neuro-oncology

JF - Neuro-oncology

ER -